Themis Medicare Limited (NSE:THEMISMED)
105.21
-2.28 (-2.12%)
Aug 1, 2025, 3:30 PM IST
bluebird bio Revenue
Themis Medicare had revenue of 987.54M INR in the quarter ending June 30, 2025, a decrease of -19.71%. This brings the company's revenue in the last twelve months to 3.80B, down -6.81% year-over-year. In the fiscal year ending March 31, 2025, Themis Medicare had annual revenue of 4.06B with 6.22% growth.
Revenue (ttm)
3.80B
Revenue Growth
-6.81%
P/S Ratio
2.54
Revenue / Employee
2.52M
Employees
1,509
Market Cap
9.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 4.06B | 237.51M | 6.22% |
Mar 31, 2024 | 3.82B | 274.38M | 7.74% |
Mar 31, 2023 | 3.54B | -402.91M | -10.21% |
Mar 31, 2022 | 3.95B | 1.64B | 71.07% |
Mar 31, 2021 | 2.31B | 290.82M | 14.43% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Mankind Pharma | 129.10B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Fortis Healthcare | 77.86B |
Aurobindo Pharma | 317.24B |